1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Sproutly Canada Inc.

Sproutly Canada Inc.

SRUTF
Sproutly Canada Inc.US flagOther OTC
0.00
USD
- -
- -
3,130.00Market Cap
Sproutly Canada Inc.
SRUTF
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2015
2016
2017
2018
2019
2020
2021
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
-0.01
-0.03
-0.02
-0.04
-0.1
-0.3
-0.06
-0.04
Basic EPS, GAAP
-0.02
- -
-0.06
-0.01
-0.06
-0.03
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.01
-0.04
-0.01
- -
0.25
-0.02
-0.05
-0.04
Book Value per Share
0.01
-0.02
0.02
0.05
0.02
-0.04
-0.02
-0.01
Tangible Book Value per Share
8
8
8
9
132
205
271
356
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
1
- -
1
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
-965.52
-718.2
-298.01
Operating Margin (%)
- -
- -
- -
- -
- -
1
- -
- -
Depreciation Expense
- -
- -
- -
- -
-13
-62
-16
-13
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
-6,646.48
-5,186.69
-2,632.35
Profit Margin (%)
- -
- -
- -
- -
2
-8
-9
-8
Working Capital
- -
- -
- -
- -
9
3
- -
- -
LT Debt
- -
- -
- -
- -
56
4
-6
-5
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
May'22
Aug'22
Nov'22
ST Debt
6
7
7
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
359
360
363
Market Capitalization
28
14
14

Working Capital

FRC

•

in mil. unless spec.
May'22
Aug'22
Nov'22
Total Current Assets
2
1
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
1
- -
Total Current Liabilities
9
9
9
Payables & Accruals
2
2
3
ST Debt
6
7
7
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
2,268.5%
-245.32%
Free Cash Flow
- -
635.3%
-83.93%
Net Income, GAAP
- -
766.47%
-73.36%
Sales/Revenue/Turnover
- -
- -
-65.86%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
1
- -
1
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
-0.02
-0.02
-0.01
- -
-0.3
2021
-0.01
-0.01
- -
- -
-0.06
2022
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
Similar Companies
IM Cannabis Corp. (IMCC)
Shineco, Inc. (TYHT)
Biostar Pharmaceuticals, Inc. (BSPM)
Orchid Pharma Limited (ORCHPHARMA.BO)
EVIO, Inc. (EVIO)
Body and Mind Inc. (BMMJ)
Business
Sproutly Canada Inc. produces and supplies water-soluble cannabis solutions and bio-natural oils to beverage and consumables markets in Canada; its core offerings include naturally water-soluble cannabis solution under the Infuz2O brand and cannabis plant oils infused into natural oils under the BNO brand, both leveraging proprietary Aqueous Phytorecovery Process (APP) Technology licensed exclusively from Infusion Biosciences Inc. for Canada, the EU, UK, Jamaica, Israel, and Australia, as well as products under the Caliber brand; the company operates a Health Canada-licensed facility in the greater Toronto area for cultivation, extraction, and production of pharmaceutical-grade cannabis delivering the full spectrum of natural bioactive molecules, targeting partnerships with established consumer brands for marketing, distribution, and commercialization of cannabis 2.0 products such as edibles, beverages, and infusions in recreational and medical segments. Founded in 2012 and headquartered at 1020 Mainland Street in Vancouver, British Columbia, Sproutly focuses on the healthcare sector within drug manufacturing for specialty and generic products, serving domestic Canadian markets through provincial sales relationships while pursuing global expansion via strategic alliances. Recent developments include ongoing debt settlements through share issuances, such as $70,000 in accrued interest converted to 1,166,666 shares at $0.06 each and $145,448 in debt settled via 2,908,968 shares at $0.05 each, alongside a letter of intent for co-packing with Kingston Cannabis Inc. utilizing advanced aluminum packaging technologies for cannabis-infused beverages, asset acquisitions from CannaHive Inc., and prior joint ventures like the 2019 partnership with Moosehead Breweries Limited for cannabis beverage development, reflecting efforts to conserve cash, enhance operational efficiency, and advance cannabis 2.0 product formulations amid regulatory compliance including a Management Cease Trade Order.